Drug General Information |
Drug ID |
D07LUI
|
Former ID |
DNC005582
|
Drug Name |
6-(4-Hydroxy-phenyl)-naphthalen-2-ol
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C16H12O2
|
Canonical SMILES |
C1=CC(=CC=C1C2=CC3=C(C=C2)C=C(C=C3)O)O
|
InChI |
1S/C16H12O2/c17-15-6-3-11(4-7-15)12-1-2-14-10-16(18)8-5-13(14)9-12/h1-10,17-18H
|
InChIKey |
SKPPZWVFPOQPOT-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Estrogen receptor |
Target Info |
Inhibitor |
[1]
|
Estrogen receptor beta |
Target Info |
Inhibitor |
[1]
|
KEGG Pathway
|
Estrogen signaling pathway
|
Prolactin signaling pathway
|
Thyroid hormone signaling pathway
|
Endocrine and other factor-regulated calcium reabsorption
|
Proteoglycans in cancerhsa04915:Estrogen signaling pathway
|
NetPath Pathway
|
FSH Signaling Pathway
|
EGFR1 Signaling Pathway
|
RANKL Signaling Pathway
|
Pathway Interaction Database
|
Regulation of nuclear SMAD2/3 signaling
|
Signaling events mediated by HDAC Class II
|
Plasma membrane estrogen receptor signaling
|
LKB1 signaling events
|
Regulation of Telomerase
|
ATF-2 transcription factor network
|
AP-1 transcription factor network
|
FOXM1 transcription factor network
|
Validated nuclear estrogen receptor alpha network
|
Signaling mediated by p38-alpha and p38-beta
|
FOXA1 transcription factor networker_nongenomic_pathway:Plasma membrane estrogen receptor signaling
|
Validated nuclear estrogen receptor beta network
|
Reactome
|
Nuclear signaling by ERBB4
|
Nuclear Receptor transcription pathwayR-HSA-383280:Nuclear Receptor transcription pathway
|
WikiPathways
|
Estrogen signaling pathway
|
Nuclear Receptors Meta-Pathway
|
Estrogen Receptor Pathway
|
Signaling by ERBB4
|
JAK/STAT
|
Integrated Pancreatic Cancer Pathway
|
Leptin signaling pathway
|
miR-targeted genes in muscle cell - TarBase
|
Integrated Breast Cancer Pathway
|
Nuclear ReceptorsWP706:SIDS Susceptibility Pathways
|
Ovarian Infertility Genes
|
Nuclear Receptors
|
References |
REF 1 | Bioorg Med Chem Lett. 2005 Oct 15;15(20):4520-5.ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives. |